CTO
Dr. Goldberg obtained her Ph.D. in Cell Biology from the Department of Cell Biology and Genetics, Erasmus MC, Rotterdam, The Netherlands, in 2009, and has since gained a wealth of experience in cancer related early-stage drug discovery activities. Dr. Goldberg has held several Senior Researcher positions at the Cancer Research Lab and the Regenerative Research Lab at the Sheba Medical Center, Israel’s largest hospital, as well as several Scientific Executive positions at companies such as Compugen and TaGeza Biopharma where she was VP of Research and Development.
